Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 810 of 6351
-
Hope for women with chronic cystitis: raphamin trial aims to stop recurring UTIs
Prevention OngoingClinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis
Phase 3 • Sponsor: Materia Medica Holding • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
Could a single gene shot replace monthly eye injections for wet AMD?
Disease control OngoingVAN-2201 is Phase I clinical trial to assess the safety and tolerability of KH631 in subjects with neovascular AMD. KH631 is gene therapy designed to deliver a protein which targets and blocks VEGF via an adeno-associated viral vector. The standard of care for patients with neova…
Phase 1 • Sponsor: Chengdu Origen Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Mind-Reading device aims to give voice to the speechless
Knowledge-focused Recruiting nowThe goal of this study is to improve our understanding of speech production, and to translate this into medical devices called intracortical brain-computer interfaces (iBCIs) that will enable people who have lost the ability to speak fluently to communicate via a computer just by…
Sponsor: Leigh R. Hochberg, MD, PhD. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New asthma drug shows promise in reducing attacks
Disease control CompletedThis is a Phase 2b, global, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the efficacy, safety, and tolerability of add-on therapy with SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New shot could help shed pounds – early trial underway
Disease control CompletedTo assess the efficacy of HRS9531 injection compared with placebo in weight reduction in overweight or obese subjects after 36 weeks of treatment.
Phase 2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Smartphone app aims to help black smokers with HIV kick the habit
Disease control CompletedThe present investigation aims to address disparities in cigarette use outcomes among Black/African American adults with HIV. The specific aims of this study are: (1) To modify a recently developed, culturally adapted, mobile application for Black smokers by integrating informati…
Sponsor: University of Houston • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Digital coaching aims to boost heart health in obesity
Disease control CompletedIn this study insufficiently active adults with obesity will be assigned to either the Physical Activity for The Heart (PATH) intervention or an attention control group.
Sponsor: Emory University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can imaging and monitoring unlock the hidden dangers of mitral valve prolapse?
Knowledge-focused OngoingThe PRIMARY trial (NCT05051033), which compares mitral valve repair (MVr) to transcatheter-edge-to-edge-repair (TEER), offers a platform for conducting mechanistic studies to develop early insights into the pathophysiological processes by which mitral valve prolapse (MVP) can imp…
Sponsor: Annetine Gelijns • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Virtual support may shield latina moms from postpartum depression
Prevention OngoingPostpartum depression (PPD) affects 10-20% of women, with immigrant Latinas disproportionately affected. PPD prevention and treatment is limited among immigrant Latinas due to an array of structural and cultural factors, suggesting the need to deliver interventions outside of tra…
Sponsor: Northwestern University • Aim: Prevention
Last updated Aug 12, 2026 00:00 UTC
-
Can brain scans and gut bacteria reveal Alzheimer's secrets?
Knowledge-focused Recruiting nowSemantic AD
Sponsor: Norwegian University of Science and Technology • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Could a parasite drug boost cancer immunotherapy? new trial investigates
Disease control Recruiting nowThis phase II trial studies the side effects and best dose of ivermectin in combination with balstilimab or pembrolizumab and to see how well they they work in shrinking tumors in patients with triple negative breast cancer that has spread to other places in the body (metastatic)…
Phase 1/2 • Sponsor: Yuan Yuan • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a booster session boost chronic pain relief?
Disease control OngoingPurpose: The overall aim is to investigate the effect of interdisciplinary rehabilitation in primary health care (PHC) for patients with chronic pain. Specific questions: What is the effect of extended access to the interdisciplinary PHC pain team + a booster session after finish…
Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Could a Blood-Stimulating drug revive failing ovaries?
Disease control CompletedThe goal of this pilot study is to improve ovarian reserve markers in patients with premature ovarian insufficiency. The main question it aims to answer is: \- Will treatment with G-CSF allow improvement in markers of ovarian reserve?
Phase 2 • Sponsor: Trio Fertility • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New drug aims to shrink Hard-to-Treat lung cancers
Disease control Recruiting nowThis study is open to adults with small cell lung cancer and other neuroendocrine tumours. The study is in people with advanced cancer for whom previous treatment was not successful or no standard treatment exists. The purpose of this study is to find a suitable dose of BI 76453…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New pill could help psoriasis on scalp, genitals, and palms
Disease control OngoingThe purpose of the study is to see how effective JNJ-77242113 is in participants with plaque psoriasis affecting special areas (scalp, genital, and/or palms of the hands and the soles of the feet).
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New hope for frail myeloma patients: phase III trial tests smarter drug combos
Disease control Recruiting nowThis phase III trial compares three-drug induction regimens followed by double-or single-drug maintenance therapy for the treatment of newly diagnosed multiple myeloma in patients who are not receiving a stem cell transplant and are considered frail or intermediate-fit based on a…
Phase 3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill could clear psoriasis in major trial
Disease control OngoingThe purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis.
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New hope for migraine sufferers: dysport shots aim to cut headache days
Disease control OngoingThe purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing chronic migraine. A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head, and is of…
Phase 3 • Sponsor: Ipsen • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for liver cancer patients with damaged livers?
Disease control CompletedLiver cancer is the third leading cause of cancer-related deaths worldwide. The majority of primary liver cancers occur as hepatocellular carcinoma (HCC), the incidence of which is increasing in many parts of the world. The vast majority of HCC cases occur in the setting of liver…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a new laser erase acne scars without harming darker skin?
Symptom relief Recruiting nowThe investigators aim to investigate the efficacy and tolerability of a hybrid non-ablative/ablative laser for acne scarring in skin of color.
Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC